ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	26/247	134/7206	3.09890948124e-13
ko04668	TNF signaling pathway	21/247	120/7206	5.01296816034e-10
ko05133	Pertussis	16/247	87/7206	3.00637882684e-08
ko04621	NOD-like receptor signaling pathway	21/247	157/7206	7.20214577254e-08
ko04623	Cytosolic DNA-sensing pathway	11/247	41/7206	7.81052359967e-08
ko05164	Influenza A	21/247	167/7206	2.11464181537e-07
ko04060	Cytokine-cytokine receptor interaction	22/247	191/7206	5.0889177537e-07
ko05323	Rheumatoid arthritis	14/247	89/7206	1.6443655688e-06
ko04657	IL-17 signaling pathway	13/247	87/7206	7.01728167662e-06
ko05140	Leishmaniasis	12/247	75/7206	7.7162648824e-06
ko04660	T cell receptor signaling pathway	15/247	124/7206	1.95792419117e-05
ko05161	Hepatitis B	18/247	173/7206	2.38123940597e-05
ko04620	Toll-like receptor signaling pathway	13/247	100/7206	3.27908505636e-05
ko04662	B cell receptor signaling pathway	12/247	88/7206	4.08421825956e-05
ko04622	RIG-I-like receptor signaling pathway	10/247	62/7206	4.17144015303e-05
ko04610	Complement and coagulation cascades	11/247	79/7206	7.04949655808e-05
ko05418	Fluid shear stress and atherosclerosis	17/247	173/7206	8.32469325918e-05
ko04064	NF-kappa B signaling pathway	12/247	96/7206	9.74180884534e-05
ko05131	Shigellosis	11/247	82/7206	9.97518934967e-05
ko05132	Salmonella infection	12/247	98/7206	0.00011921863322
ko05142	Chagas disease (American trypanosomiasis)	14/247	130/7206	0.000134401501061
ko00643	Styrene degradation	3/247	4/7206	0.000155160041226
ko04666	Fc gamma R-mediated phagocytosis	13/247	122/7206	0.000259117465203
ko05167	Kaposi's sarcoma-associated herpesvirus infection	17/247	191/7206	0.000278972922723
ko05145	Toxoplasmosis	13/247	126/7206	0.000356657018182
ko04210	Apoptosis	16/247	180/7206	0.000427360911817
ko05168	Herpes simplex infection	16/247	182/7206	0.000483465966704
ko04630	Jak-STAT signaling pathway	13/247	132/7206	0.000560736525386
ko05152	Tuberculosis	16/247	187/7206	0.000652160270971
ko04933	AGE-RAGE signaling pathway in diabetic complications	13/247	135/7206	0.000695253764357
ko05120	Epithelial cell signaling in Helicobacter pylori infection	10/247	92/7206	0.00113624091106
ko05150	Staphylococcus aureus infection	6/247	36/7206	0.00125193078885
ko04672	Intestinal immune network for IgA production	6/247	37/7206	0.00145207860192
ko05160	Hepatitis C	13/247	153/7206	0.00220318832221
ko05210	Colorectal cancer	9/247	86/7206	0.00259593297503
ko05162	Measles	11/247	120/7206	0.00263094761381
ko05134	Legionellosis	8/247	74/7206	0.00363093680373
ko01524	Platinum drug resistance	8/247	76/7206	0.0042842210242
ko04650	Natural killer cell mediated cytotoxicity	9/247	97/7206	0.00582807626195
ko05100	Bacterial invasion of epithelial cells	9/247	99/7206	0.00665485573755
ko05146	Amoebiasis	9/247	99/7206	0.00665485573755
ko00982	Drug metabolism - cytochrome P450	5/247	37/7206	0.00807721933192
ko04917	Prolactin signaling pathway	8/247	87/7206	0.00962912900372
ko04062	Chemokine signaling pathway	14/247	201/7206	0.0098205103137
ko04217	Necroptosis	13/247	178/7206	0.00984372543556
ko04932	Non-alcoholic fatty liver disease (NAFLD)	13/247	182/7206	0.0111556913838
ko00980	Metabolism of xenobiotics by cytochrome P450	5/247	40/7206	0.0112223101312
ko04611	Platelet activation	12/247	163/7206	0.0131843196027
ko04658	Th1 and Th2 cell differentiation	8/247	96/7206	0.0168219410264
ko05034	Alcoholism	2/247	238/7206	0.0177991095321
ko05144	Malaria	5/247	45/7206	0.0181558697518
ko04670	Leukocyte transendothelial migration	11/247	151/7206	0.0192863303457
ko04144	Endocytosis	20/247	342/7206	0.0206363812094
ko04215	Apoptosis - multiple species	5/247	47/7206	0.0215770660026
ko05204	Chemical carcinogenesis	5/247	48/7206	0.0234346866456
ko04624	Toll and Imd signaling pathway	5/247	49/7206	0.0253926694796
ko04931	Insulin resistance	10/247	137/7206	0.0269950372936
ko04659	Th17 cell differentiation	8/247	106/7206	0.0286500805722
ko05166	HTLV-I infection	17/247	292/7206	0.030900105414
ko04723	Retrograde endocannabinoid signaling	1/247	175/7206	0.0321298647623
ko04920	Adipocytokine signaling pathway	7/247	89/7206	0.0324991997917
ko04080	Neuroactive ligand-receptor interaction	7/247	423/7206	0.0378297200723
ko05416	Viral myocarditis	5/247	55/7206	0.0393274922306
ko04115	p53 signaling pathway	6/247	74/7206	0.0406903684547
ko05321	Inflammatory bowel disease (IBD)	5/247	56/7206	0.0420247263756
ko05020	Prion diseases	4/247	40/7206	0.0469260871762
ko04664	Fc epsilon RI signaling pathway	6/247	77/7206	0.0479089655693